Jonathan Goldman, Director: Avalo Therapeutics AVTX Sell · Filed 25/11/17

Trade details

Type: Insider sale
Amount: $117,670
Shares · price: 8,200 sh · $14.35 a share
Held after: 0 sh
Stock: Avalo Therapeutics AVTX
Person: Jonathan GoldmanDirector
Trade date: 25/11/14
Filed: 25/11/17
Days to filing: 3 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Avalo Therapeutics trades, last 26 weeks

What else happened in Avalo Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/15~25/12/14

Jonathan Goldman's recent trades

Jonathan GoldmanDirector
Planned saleAvalo Therapeutics
Planned sale
Avalo Therapeutics
AVTX
$616.2K
42,833 sh
$616.2K
Filed 06/02
Traded 06/02
Jonathan GoldmanDirector
SellAvalo Therapeutics
Sell
Avalo Therapeutics
AVTX
$45.3K
3,167 sh
$45.3K
Filed 25/11/17
Traded 25/11/14

Jonathan Goldman, Director — sold $117.7K of Avalo Therapeutics AVTX · 100.0% of holdings | Whalegun